6.77
-0.08(-1.17%)
Currency In USD
| Previous Close | 6.85 |
| Open | 6.72 |
| Day High | 6.84 |
| Day Low | 6.46 |
| 52-Week High | 7.99 |
| 52-Week Low | 3.68 |
| Volume | 154,287 |
| Average Volume | 274,969 |
| Market Cap | 250.66M |
| PE | -4.61 |
| EPS | -1.47 |
| Moving Average 50 Days | 6.55 |
| Moving Average 200 Days | 6.15 |
| Change | -0.08 |
If you invested $1000 in Lifecore Biomedical, Inc. (LFCR) 10 years ago, it would be worth $470.79 as of June 01, 2025 at a share price of $6.77. Whereas If you bought $1000 worth of Lifecore Biomedical, Inc. (LFCR) shares 5 years ago, it would be worth $624.54 as of June 01, 2025 at a share price of $6.77.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Lifecore Biomedical Names Mark DaFonseca Chief Commercial Officer
GlobeNewswire Inc.
May 27, 2025 11:00 AM GMT
Mr. DaFonseca Possesses Nearly 30 Years of Broad Drug Development Experience, including More than 15 Years Leading High Performing CDMO Sales Organizations Will Leverage Deep Pharma Services Expertise as Leader of Lifecore’s Sales Organization Focuse
Lifecore Biomedical to Participate at Upcoming CDMO Live 2025 Conference
GlobeNewswire Inc.
Apr 22, 2025 11:00 AM GMT
CHASKA, Minn., April 22, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in the upcom
Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire Inc.
Apr 16, 2025 8:05 PM GMT
CHASKA, Minn., April 16, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that Lifecore granted a restricted stock unit (